First patient dosed with first-in-class SMARCA2(BRM) selective inhibitor FHD-909 (LY4050784) in Phase 1 trial with primary target population in ...

An international team led by researchers at the University of Toronto has developed an efficient and robust system, using the C. elegans nematode, to screen for compounds that can stop the growth of ...

Small-cap exchange-traded funds can boost returns and improve diversification under the right circumstances. Still, recent results highlight that small-cap investing is not without risks and that ...

Amazon said Wednesday it’s investing in projects to develop small modular nuclear reactors, or SMRs. The announcement comes days after Google unveiled a similar plan, as both companies seek to ...